External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Diabetic Macular Edema

DME is a vision-threatening eye condition that affects people with type 1 and type 2 diabetes, characterized by the accumulation of fluid from leaky vessels resulting in swelling of the macula, and is a leading cause of vision loss globally. Roche is committed to the development of new treatments and treatment strategies that optimize vision outcomes to improve the lives of patients and their caregivers.

What's new

Ask a question or share feedback